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Abstract 
Background: The guided bone regeneration (GBR) technique is highly successful for the treatment of peri-implant 
bone defects. The aim was to determine whether or not implants associated with GBR due to peri-implant defects 
show the same survival and success rates as implants placed in native bone without defects.
Material and Methods: Patients with a minimum of two submerged dental implants: one suffering a dehiscence or 
fenestration defect during placement and undergoing simultaneous guided bone regeneration (test group), versus 
the other entirely surrounded by bone (control group) were treated and monitored annually for three years. Com-
plications with the healing procedure, implant survival, implant success and peri-implant marginal bone loss were 
assessed. Statistical analysis was performed with non-parametric tests setting an alpha value of 0.05.
Results: Seventy-two patients and 326 implants were included (142 test, 184 control). One hundred and twenty-five 
dehiscences (average height 1.92±1.11) and 18 fenestrations (average height 3.34±2.16) were treated. At 3 years 
post-loading, implant survival rates were 95.7% (test) and 97.3% (control) and implant success rates were 93.6% 
and 96.2%, respectively. Mean marginal bone loss was 0.54 (SD 0.26 mm) for the test group and 0.43 (SD 0.22 
mm) for the control group. No statistically significant differences between both groups were found.
Conclusions: Within the limits of this study, implants with peri-implant defects treated with guided bone regene-
ration exhibited similar survival and success rates and peri-implant marginal bone loss to implants without those 
defects. Large-scale randomized controlled studies with longer follow-ups involving the assessment of esthetic 
parameters and hard and soft peri-implant tissue stability are needed.
Key words: Guided bone regeneration, peri-implant defects, dental implants, marginal bone level, success rate, 
survival rate.
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Introduction
Horizontal alveolar bone defects often result in a dehis-
cence or a fenestration defect exposing part of the im-
plant surface (1,2). Several clinical studies have shown 
that at least 1mm of bone width buccal and lingual to 
the implant surface is needed to ensure long-term bone 
coverage and therefore implant success (3,4). When this 
is lacking at the moment of implant placement, guided 
bone regeneration has been proposed to augment the 
bone width in a single simultaneous surgical interven-
tion (5,6).
An important issue is whether or not implants placed in 
sites associated with bone regeneration provide survival 
and success rates similar to those of implants placed in 
sites with sufficient native bone (7). Although there are 
a variety of case series studies on bone regeneration, 
three systematic reviews (1,8,9) on implant survival in 
sites regenerated with GBR identified only three studies 
(10-12) that compared implants with peri-implant de-
fects that required bone grafts versus implants entirely 
surrounded by pristine bone as control implants in their 
analysis.
The purpose of the present study was to retrospectively 
evaluate whether or not implants associated with bone 
regeneration due to peri-implant defects show the same 
survival and success rates as implants placed in native 
bone without such defects, and to evaluate long-term 
outcomes of implants with dehiscences and fenestrations 
treated with guided bone regeneration with a minimum 
follow-up of three years post-loading.
Subject and site inclusion criteria:
A minimum of two dental implants, one with a dehiscence or fenestration bony defect during implant place-- 
ment treated with particulate bone graft and resorbable membranes (Test Group), and another implant entirely 
surrounded by bone (Control Group).
Submerged implants- 
Tooth/teeth at implant site extracted >6 months previously- 
Rehabilitation with fixed or removable implant-supported prosthesis - 
Age > 18 years- 
No relevant medical conditions- 
Non-smoking or smoking - ≤ 20 cigarettes/day (all pipe or cigar smokers were excluded)
Follow-up for at least three years after prosthetic loading - 
Subject and site exclusion criteria:
Patient’s with systemic or local conditions contraindicating implant therapy (previous chemotherapy, previous - 
irradiation of the head and neck region, active progressive periodontitis and/or immunosuppression).
Pregnant and lactating patients- 
Sites with acute infection- 
Poor oral hygiene- 
Implants with sinus augmentation- 
Immediate implants or placed in a bone with a recent extraction (less than six months)- 
Re-implants- 
Implants placed in bone previously regenerated with bone grafts.- 
Patients failing to attend follow-up visits- 
Table 1. Inclusion and exclusion criteria.
Material and Methods 
-Patient selection
A retrospective controlled clinical study was made of 
patients with a minimum of two dental implants, one 
implant demonstrating a dehiscence or fenestration bony 
defect with exposed implant surface during implant 
placement and so undergoing simultaneous particulate 
bone grafting with resorbable membranes (test group), 
and the other implant site entirely surrounded by bone 
(control group). All implants had to be left submerged. 
Patients were treated between January 2005 and Dec-
ember 2009 at the Oral Surgery Unit of the University 
of Valencia in Spain and were monitored annually for a 
minimum of 3-years post-loading. Patients were given 
full information about the surgical procedures and duly 
signed informed consent forms. Preoperative analysis 
included registering complete medical histories and per-
forming clinical and radiographic examinations. Inclu-
sion and exclusion criteria are detailed in table 1. The 
present study is reported in accordance with the STRO-
BE (Strengthening the Reporting of Observational Stu-
dies in Epidemiology) statement (13).
-Pre-Operative Evaluation
Thorough medical histories, clinical examinations and 
panoramic radiographs were performed in all cases. 
Cone-beam computed tomographic scans were obtained 
to assess the availability of bone whenever the surgeon 
considered this necessary. Periodontal treatment was 
provided whenever necessary to control inflammation 
prior implant placement surgery. Within 10 days of the 
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implant placement surgery, a full mouth professional 
prophylaxis appointment was scheduled.
-Surgical procedures
Surgical procedures were performed by the same sur-
geon with an extensive experience in regenerative pro-
cedures. All procedures were performed under local 
anesthesia using 4% articaine 1:100,000 adrenalin (Ini-
bsa, Lliça de Vall, Spain) and intravenous conscious se-
dation with 1% propofol solution, administered by an 
anesthesiologist. All patients received antibiotic pro-
phylaxis (amoxicillin and clavulanic acid, 1g every 8 
hours starting 1 day preoperatively (14)). An initial in-
cision was made slightly palatal/lingual of the alveolar 
crest. One or two releasing incisions were made and a 
mucoperiosteal flap was raised. The exposed alveolar 
bone was curetted to remove all soft tissues. To enhance 
primary stability, drills and osteotomes were combined 
to prepare implant beds. TSATM implants with Avant-
blast surface (Phibo Dental Solutions S.L., Sentmenat, 
Barcelona, Spain) were inserted using standard proce-
dures following the manufacturer’s guidelines. These 
implants have a polished surface portion of 1.5 mm. All 
implants were placed with adequate primary stability 
(≥35 Ncm). In implants that did not need bone regene-
ration, bone width from the implant head to the facial 
plate was over 1.5 mm. In implants that needed bone 
regeneration, autologous bone grafts harvested from the 
conformation of implant beds during drilling and was 
adjusted to the bone contour. When the autologous bone 
obtained was of insufficient quantity to cover the peri-
implant defects, synthetic bone (Kera-OsTM, Keramat, 
Coruña, Spain) was added. Grafted bone was protected 
with a textured collagen membrane (Lyopstic, B Braun, 
Aesculap, Germany). Periosteal incisions were made to 
allow flap mobilization and tension free primary wound 
closure. Implants were left submerged. Flaps were clo-
sed with horizontal sutures using Polisoft® 4/0 sutures 
(Sweden & Martina, Due Carrare, Italy) (Figs. 1-10). 
Fig. 1. Occlusal preoperative view.
Fig. 2. Dental implants placed in 4.5, 4.6 and 4.7 position.
Fig. 3. Autogenous bone graft over dehiscence.
Fig. 4. Resorbable membrane over bone graft.
Patients were prescribed amoxicillin and clavulanic acid 
1g (GlaxoSmithKline, Madrid, Spain) twice daily for six 
days, 600 mg ibuprofen (Bexistar, Laboratorio Bacino, 
Barcelona, Spain) three times per day for five days and 
mouthrinse with chlorhexidine 0.12% (GUM, John O 
Butler/Sunstar, Chicago, IL, U.S.A.) twice daily, com-
mencing three days prior to surgery and for two weeks 
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Fig. 5. Suture.
Fig. 6. Panoramic radiography after implant placement.
Fig. 7. Healed soft tissues. Fig. 8. Final prosthesis place-
ment.
Fig. 9. Frontal view after final prosthesis placement.
Fig. 10. Panoramic radiography after final prostheses placement.
thereafter. Patients were instructed in adequate hygiene 
maintenance and a soft diet was recommended for eight 
weeks. Patients were not allowed to use removable pros-
theses for three weeks after bone grafting surgeries. A 
soft diet was recommended for one week and patients 
were instructed to avoid brushing or any other trauma 
to the surgical sites. Sutures were removed two weeks 
after surgery.
Second surgeries were performed two or three months 
after implant placement and final fixed prostheses were 
placed one month later.
-Data collection and follow-up
All data collection was carried out by a single trained 
clinician, different from the surgeons or the prosthodon-
tist, following a pre-established protocol. All patients 
were included in a maintenance program involving an-
nual examinations and professional prophylaxis.
Patient age (at implant placement), gender, hygiene and 
smoking habits (none / <10 cigarettes per day / 10-20 
cigarettes per day) were registered. For each implant, the 
position, and the type and dimensions of defects (dehis-
cence/fenestration) were registered. Defects were mea-
sured using a millimetric periodontal probe (Hu-Friedy 
UNC, Chicago, IL, USA) placed parallel or perpendicu-
lar to the long axis of the implant. Measurements were 
recorded to the nearest 1mm mark. The use of temporary 
prostheses (yes or no), definitive prosthesis design (sin-
gle, partial or complete – fixed or overdenture) and type 
of prosthesis (cemented or screwed) were recorded.
All patients were included in a maintenance program 
involving annual examinations and occlusal adjustment 
was performed when necessary.
The following outcome measures were recorded:
Receptor site healing: Wound dehiscence with bone gra-
ft exposure.
Implant survival: The criteria for implant failure were im-
plant mobility or the removal of stable implants due to 
progressive peri-implant marginal bone loss or infection. 
Implant success: The definition of implant success 
was based on the clinical and radiographic criteria put 
forward by Albrektsson et al. (15).
Radiographic peri-implant marginal bone loss: Intrao-
ral radiographs were made at the moment of prosthetic 
J Clin Exp Dent. 2015;7(3):e361-8.                                                                                                                                                       Implants with versus without defects treated GBR
e365
loading (baseline), one-year post-loading and at 3 year 
control radiograph, using the X-MindTM intraoral sys-
tem (Satelec-Pierre Rolland Group, Merignac, France) 
and an RVGTM intraoral digital receptor (Dürr Dental, 
Bietigheim-Bissingen, Germany) with the aid of a Rinn 
XCPTM (Dentsply Rinn, Elgin, IL, U.S.A.) to achieve 
parallelism. Evaluation of the marginal bone level around 
implants was performed using image analysis software 
(Autocad 2006, version Z 54.10, Autodesk, USA), which 
is designed to compensate for radiographic distortion. 
Each image was calibrated using the known length of 
the implants. The vertical distance from the outer edge 
of the implant shoulder (reference point) to the most co-
ronal point of bone-to-implant contact was evaluated at 
the mesial and distal aspect of each implant. Peri-im-
plant marginal bone resorption at 3-year post-loading 
was calculated from the change in bone level between 
the 1-year post-loading and the 3-year control radiogra-
ph; for each pair of measurements (mesial and distal) the 
largest value was used. Intra-examiner calibration was 
analyzed before evaluating the entire implant sample by 
reassessing bone loss at a total of 30 randomly selec-
ted sites (using the random function of Microsoft Excel 
2010) on duplicate measurements performed on different 
days. An intraclass correlation coefficient of 0.833 was 
obtained, showing a high concordance between the two 
sets of data. According to Dahlberg’s d-value, a 0.046 
mm error was estimated for the measurement method.
-Statistical Analysis 
Statistical analysis was performed using non-parametric 
tests for implant success, as this was a non-continuous 
variable, and marginal bone loss, as this was an asym-
metric distribution. The Chi2 test and the Mann-Whitney 
test (MW) were used to evaluate homogeneity within the 
two groups in relation to the demographic factors, clini-
cal parameters, implant survival and success rates. The 
MW test was used to compare bone loss between groups. 
The relationship between the implant failure and bone 
loss with respect to age, gender, smoking and hygiene 
habit, position and location of the implants, type defect 
and defect dimensions or type of graft was studied with 
non-parametric tests. The statistical power for this test 
was 99.5% to detect an effect of 0.27 with a confidence 
of 95% and alpha set at 0.05. Statistical analysis was 
performed using SPSS 17.0 software (SPSS Inc. Chica-
go, IL, U.S.A.).
Results
A total of 129 patients with submerged dental implants 
placed with dehiscences and fenestrations and treated 
with particulate bone graft and implants without these 
bony defects in the same patient were included. Eleven 
patients were excluded as a result of failing to attend the 
scheduled recall visits and 20 because control implants 
were not submerged.
The final study sample included 72 patients (37 women 
and 35 men) with a mean age of 55.4 ± 11.7 (25-87). 
Hygiene maintenance was good in 47 patients and re-
gular in 25. Forty-eight patients were non-smokers, 11 
smoked less than 10 cigarettes per day, 7 between 10 and 
20 cigarettes and 6 were ex-smokers.
A total of 326 dental implants (142 test group, 184 control 
group) were placed. Out of 183 implants in test group, 
162 had dehiscences and 21 with fenestrations. The mean 
dimensions of the resulting dehiscence defects were: 
1.92±1.11 mm (range 1-6) length and 3.29 mm (range 3 
to 5.5 mm) width. The mean dimensions of the resulting 
fenestration defects were: 3.34±2.16 mm (range 1-8) and 
2.1 mm (range 1.5 to 3 mm) width. The distribution of 
patient or implant variables is described in table 2. No sta-
tistically significant differences were found between the 
two study groups regarding implant variables.
-Receptor site healing
Wound dehiscence with membrane exposure during the 
early postoperative period occurred in twelve grafted si-
tes in twelve patients (8.4% membrane exposure rate). 
These exposures did not exceed 3mm in diameter. In 
these cases, 0.2% chlorhexidine gel was prescribed three 
times daily over the exposed membrane for 6 weeks af-
ter surgery. All sites re-epithelialized uneventfully.
Table 2. Description of implants distribution sample.
N implants Group 1 (142) Group 2 (184) Test p
Arch Maxillary 69 88 Chi2 0.18 
Mandibular 83 86 
Position Anterior 47 32 Chi2 <0.01 
Posterior 95 152 
Temporary prostheses Yes 1 5 Chi2 0.236 
No 182 230 
Prostheses design Single 28 37 Chi2 0.21 
Partial 89 87 
Hybrid 13 32 
Full arch 5 17 
Overdenture 7 11 
Type prostheses Cemented 64 63 Chi2 0.06 
Screwed 42 67 
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-Implant survival, success rates, and peri-implant mar-
ginal bone loss
Seven implants in seven patients in the test group were 
lost, all of them before loading. Five implants in four 
patients in the control group failed to osseointegrate and 
were removed, four before loading and one after loading 
(at eight months after loading). The distribution of im-
plant failures is described in table 3.
Implant survival rates were 95.7% for the test group 
and 97.3% for the control group; the difference was not 
statistically significant (p-value = 0.542). Mean peri-
implant marginal bone loss one year after 1-year loading 
was 0.44 mm (range 0.1-1.7, SD 0.27 mm) for the test 
group and 0.39 mm (range 0.1-1.3, SD 0.23 mm) for 
the control group. Bone loss was slightly higher for im-
plants placed in grafted bone, although differences were 
not statistically significant (p=0.213).
At 3 years post-loading, no further implants were lost. 
93.6% of the implants in the test group and 96.2% in the 
control group showed stable alveolar bone levels; no sta-
tistically significant differences were found (p=0.587). 
Mean peri-implant marginal bone loss at 3 years post-
loading was 0.54 mm (range 0.1-2.1, SD 0.26 mm) for 
the test group and 0.43 mm (range 0.1-1.7, SD 0.22 mm) 
for the control group. Differences between both groups 
were not statistically significant (p=0.893).
No significant differences were found between implant 
failures/bone loss and patient factors (age, gender, smo-
king habit) or implant variables (location, type defect, 
defect dimensions, prostheses). However, implant failu-
res were more frequent among patients with a regular 
oral hygiene (91.6%) than good (8.4%); these results 
showed a moderate tendency to significance but were 
nevertheless non-significant (p-value 0.06).
Discussion
Peri-implant bone defects occurring during the surgical im-
plant placement procedure are a frequent problem in daily 
practice, one with considerable clinical relevance. For this 
reason, the present study set out to evaluate the long-term 
outcome of implants with dehiscences and fenestrations 
treated with guided bone regeneration with a minimum 
follow-up of three years. The study analyzed complications 
associated with guided bone regeneration, implant survival 
and success rates and peri-implant marginal bone loss.
Soft tissue thickness and primary flap closure are im-
portant aspects of surgery for the maintenance of wound 
stability during healing16. Early exposure of the mem-
brane, with consequential bacterial contamination of 
the healing tissues, hinders bone regeneration, despite 
careful remedy with chlorhexidine applications (17,18). 
Nowzari and Slots (19) showed that implant sites with 
submerged barrier membranes remained free of cultiva-
ble microorganisms throughout their nine-month study 
and experienced significantly more osseous healing than 
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sites with prematurely exposed membranes. The appli-
cation of chlorhexidine has been recommended for ca-
ses of membrane exposure (2,3). In the present study, 
wound dehiscence with membrane exposure occurred at 
twelve grafted sites in twelve patients during the early 
postoperative period.
There is insufficient evidence in the literature in support 
of the need to cover the dehiscence and fenestrations for 
ensuring long-term implant survival (20). To address this 
issue, randomized clinical trials that compare treatment 
with GBR vs. non-treatment of fenestrations/dehiscences 
should be performed. But to date, no research has been 
published with these precise characteristics. Dahlin et al. 
(21) conducted the first split-mouth study on implants 
(machined titanium) with fenestrations treated with or 
without e-PTFE membrane; there was a significant bone 
gain in the group treated with GBR in comparison with 
the non-treated group, but there was no difference in 
the implant survival rates between groups. The authors 
showed that membranes alone, without the additional aid 
and sustenance provided by graft materials, will allow 
the formation of new bone; however, it could not be de-
monstrated that the realization of this bone augmentation 
was necessary for implant survival. The present article 
was only able to demonstrate that dehisced implants, if 
properly treated with grafting materials and membranes, 
may lead to a survival rate of implants similar to that ob-
tained in implants completely embedded in native bone, 
but it was not designed to demonstrate whether GBR is 
really needed in case of fenestrations/dehiscences.
Only four studies have set out to determine whether 
the survival of implants with bone defects treated with 
peri-implant regenerative procedures is comparable 
to implants without defects in the same patient (7,10-
12). According to these studies, survival and success 
rates were not significantly different between implants 
in regenerated and non-regenerated bone. In the pre-
sent study, implant survival rates were 95.7% (test) and 
97.3% (control) and implant success rates were 93.6% 
and 96.2%, respectively, at 3 years post-loading. These 
results compare well with systematic reviews reporting 
survival rates of implants placed into sites with regene-
rated bone ranging from 79% to 100%, with the majo-
rity of studies indicating >90% after at least 1 year of 
function (9,22). The survival rates obtained in these 
systematic reviews were similar to those reported in the 
meta-analysis of prospective longitudinal studies for im-
plant therapy with and without bone regeneration after 
at least 5 years (23).
The assessment of bone levels around implants with 
buccal or lingual defects presents a methodological cha-
llenge. Schliephake et al. (24) showed that determining 
peri-implant bone levels from periapical radiographs, re-
formatted CT scans or direct magnification imaging does 
not provide valid data on the circumferential bone level 
in implants with buccal bone defects, but does genera-
lly reflect the bone level on the lingual side. Periapical 
radiographs were found to obtain the best correlation, 
though they tend to overestimate the bone anchorage of 
these implants. Authors such as Mayfield et al. (10) have 
hypothesized that distal and mesial marginal bone va-
lues reflect the buccal bone margin. Jung et al. (5) found 
minimal mean changes (0.03-0.13mm) of the marginal 
bone level at test sites and control sites between baseli-
ne, 3- and 5-year examinations. In a retrospective mul-
ti-center study, the mean radiographic bone loss over a 
74-month period of implants loaded in regenerated bone 
was 0.64mm (0.3-0.8mm) (25). A further mean annual 
crestal bone loss ranging from 0.05-0.13mm after the 
first year of function (i.e. after abutment connection) has 
been reported (26-27). In this study, mean peri-implant 
marginal bone loss after 3-years post-loading was 0.54 
± 0.26 mm for the test group and 0.43 ± 0.22 mm for the 
control group, without significant differences between 
groups. These results demonstrated that bone regene-
rated by GBR in peri-implant bone defects remains as 
stable over time as pristine periimplant bone. These data 
compare well with results reported in previous studies 
including implants in pristine as well as regenerated 
bone (10,12). 
In the present study, re-entries were not performed, so it 
provides no evidence on the effectiveness of this techni-
que on bone regeneration. In addition, it should be noted 
that all procedures were performed by the same oral sur-
geon with extensive clinical experience in regenerative 
procedures, which may limit the extrapolation of the re-
sults. Nevertheless, the lack of appropriate controls and 
the lack of good outcome measurements that assess aes-
thetic demands preclude definitive conclusions. Further 
long-term studies with appropriate controls and larger 
sample sizes with longer follow-ups should be conduc-
ted in order to confirm or reject these findings.
Conclusions
Within the limits of this study, implants with peri-im-
plant defects treated with guided bone regeneration 
exhibited similar survival and success rates, and peri-
implant marginal bone loss to implants without these 
defects. Implant survival and success rates were high in 
both groups; marginal bone levels were within the range 
of published data.
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